Pain News and Research

Latest Pain News and Research

Hypnosis may help reduce pain and suffering in metastatic breast cancer patients

Hypnosis may help reduce pain and suffering in metastatic breast cancer patients

Surge in volunteers without overall coordination can make devastating situation worse instead of better

Surge in volunteers without overall coordination can make devastating situation worse instead of better

Baby Angels Foundation established to support bereaved parents in Minnesota and western Wisconsin

Baby Angels Foundation established to support bereaved parents in Minnesota and western Wisconsin

Integrative oncology program aims to address cancer patients' needs from every angle

Integrative oncology program aims to address cancer patients' needs from every angle

Heel pain continues to be the most common reason patients seek care, say foot and ankle surgeons

Heel pain continues to be the most common reason patients seek care, say foot and ankle surgeons

New Robotic Surgical Simulator created for robot-assisted surgery

New Robotic Surgical Simulator created for robot-assisted surgery

Surgeons perform nation's first incision-free myotomy procedure to treat achalasia

Surgeons perform nation's first incision-free myotomy procedure to treat achalasia

New fatigue rating scale predicts increased risk of heart attack in dialysis patients

New fatigue rating scale predicts increased risk of heart attack in dialysis patients

Connecticut has especially high insurance hikes, disability advocates worry about Medicaid cuts in Tennessee

Connecticut has especially high insurance hikes, disability advocates worry about Medicaid cuts in Tennessee

TMI's Glider balloon catheter for PTA of lesions in peripheral vasculature receives FDA marketing clearance

TMI's Glider balloon catheter for PTA of lesions in peripheral vasculature receives FDA marketing clearance

Sales revenue from Labopharm's once-daily tramadol increases to $4.7M for fourth-quarter fiscal 2009

Sales revenue from Labopharm's once-daily tramadol increases to $4.7M for fourth-quarter fiscal 2009

OncoGenex Pharmaceuticals receives CHMP advice on OGX-011 development plan in treatment of mCRPC

OncoGenex Pharmaceuticals receives CHMP advice on OGX-011 development plan in treatment of mCRPC

Family violence survivors: Enhancing resilience a promising therapy

Family violence survivors: Enhancing resilience a promising therapy

NIH panel proposes multiple management strategies for lactose intolerant individuals

NIH panel proposes multiple management strategies for lactose intolerant individuals

Soy products meet nutritional needs of people with lactose intolerance

Soy products meet nutritional needs of people with lactose intolerance

Study: People can reduce their sensitivity to pain by thickening their brain

Study: People can reduce their sensitivity to pain by thickening their brain

Orexo partner submits NDA for cancer pain drug Abstral in Japan

Orexo partner submits NDA for cancer pain drug Abstral in Japan

MicroTransponder awarded $2.6M NINDS SBIR FastTrack U44 grant, announces $7M Series B funding

MicroTransponder awarded $2.6M NINDS SBIR FastTrack U44 grant, announces $7M Series B funding

JVC offers treatment for vascular diseases and thrombotic disorders under one roof

JVC offers treatment for vascular diseases and thrombotic disorders under one roof

EpiCept provides business update and fourth-quarter financial highlights

EpiCept provides business update and fourth-quarter financial highlights

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.